FDA Inspection 1147623 — Armstrong Pharmaceuticals, Inc.
The FDA completed an inspection of Armstrong Pharmaceuticals, Inc. on Jul 14, 2021 in Canton, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 14, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Canton, MA (United States)